Akero Therapeutics, Inc. (AKRO)
NASDAQ: AKRO · Real-Time Price · USD
48.19
+0.07 (0.15%)
At close: Aug 27, 2025, 4:00 PM
48.18
-0.01 (-0.02%)
After-hours: Aug 27, 2025, 5:04 PM EDT

Akero Therapeutics Stock Forecast

Stock Price Forecast

The 7 analysts that cover Akero Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $81.57, which forecasts a 69.27% increase in the stock price over the next year. The lowest target is $64 and the highest is $109.

Price Target: $81.57 (+69.27%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$64$81.57$76$109
Change+32.81%+69.27%+57.71%+126.19%

Analyst Ratings

The average analyst rating for Akero Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingMar '25Apr '25May '25Jun '25Jul '25Aug '25
Strong Buy555556
Buy443331
Hold000000
Sell000000
Strong Sell000000
Total998887

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
TD Cowen
TD Cowen
Strong Buy
Initiates
$76
Strong BuyInitiates$76+57.71%Aug 4, 2025
B of A Securities
B of A Securities
Strong Buy
Maintains
$63$64
Strong BuyMaintains$63$64+32.81%May 27, 2025
Citigroup
Citigroup
Strong Buy
Maintains
$80$78
Strong BuyMaintains$80$78+61.86%May 13, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$72$75
Strong BuyMaintains$72$75+55.63%Mar 3, 2025
UBS
UBS
Strong Buy
Maintains
$42$109
Strong BuyMaintains$42$109+126.19%Jan 31, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.81
from -3.75
EPS Next Year
-4.50
from -3.81
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
-------
Revenue Growth
-------
EPS
-2.52-2.89-2.87-2.89-3.75-3.81-4.50
EPS Growth
-------
Forward PE
-------
No. Analysts
-----1413
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth20252026202720282029
High--
Avg--
Low--

EPS Forecast

EPS20252026202720282029
High-3.76-4.34
Avg-3.81-4.50
Low-4.08-4.80

EPS Growth

EPS Growth20252026202720282029
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.